Richard Murphy, neuroscientist and former CEO of San Diego's Salk Institute of Biological Sciences, will serve as interim president at the California Institute for Regenerative Medicine, replacing Lori Hoffman, the institute's chief financial officer who has served as president since May.CIRM's governing board, the Independent Citizens Oversight Committee, or ICOC, approved Murphy's six month, $300,000 contract on Wednesday (August 8).CIRM, which was created in 2004, is responsible for meting out the $3 billion in stem cell research funding made available by the passage of California's Proposition 71. Murphy's term as president will begin September 1 and will end in early March of next year."My job as president is going to be, first and foremost, to make sure the operation of CIRM is efficient and effective," Murphy told The Scientist. Murphy, who served on the ICOC from 2005 until July, said he will also be responsible for...

Interested in reading more?

Become a Member of

Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!